A melanoma drug shows promise for NF1 plexiforms | Children's National

A melanoma drug shows promise for NF1 plexiforms | Children's National

Melanoma drug shows promise for NF1 plexiforms A class of drugs originally approved for stopping tumor growth in adult cancers may be the key to treating plexiform neurofibromas in neurofibromatosis type 1 (NF1), too. If effective, doctors will finally have a treatment to offer for children with complicated plexiform neurofibromas that can’t be removed via surgery.